Career Opportunities

Mucosis B.V. is a young Dutch biotechnology company developing innovative mucosal vaccines that can be applied needle-free via the nose or mouth. Mucosis’s lead product candidates are FluGEM™, an intranasal vaccine to prevent influenza, and PneuGEM™, a vaccine to prevent pneumonia and mid ear infections. Our vaccines are based on Mimopath™, a unique technology that enables a robust natural immune response as well as a broad base of protection.

Mucosis is searching for team players with relevant experience in biotech industry:


Research Technician

Job description:

We are looking for an enthusiastic all round technician with experience in the field of ELISAs, protein and DNA techniques, bacterial fermentations, cell culture, etc.

Your function:

  • Analyses of vaccine test samples
  • Manufacturing of vaccines


Up/downstream Protein Specialist

Job description:

We are looking for an ambitious scientist with a track record in the field of upstream and downstream protein processing.

Your function:

  • Set up protein production, isolation and formulation procedures for vaccine manufacturing purposes


More information:
dr. Kees Leenhouts, tel. 050-8200053 / 06-46307495.

Send your application (Dutch or English), including CV to:

Mucosis BV,
Kees Leenhouts,
CSO,
LJ Zielstraweg 1,
9713 GX Groningen,

or via e-mail:info@mucosis.com
Please indicate job reference: 2010BC

31.05.10 Mucosis receives financial support from the Dutch government for its FluGEM program
more >

27.04.10 Mucosis appoints Dr. Roberto Grimandi as chief medical officer
more >

22.09.09 Mucosis receives key US patent covering its Mimopath™ technology
more >

28.01.09 Mucosis B.V. and PATH start development of pneumococcal vaccines
more >

15.12.08 Mucosis B.V. and TNO announce flu vaccine research and development partnership.
more >

10.12.07 News article in “Het Financieele Dagblad”.
more >

06.11.08 Mucosis B.V. appoints Dr. Govert Schouten as CEO. more >

10.09.07 Mucosis raises € 3 million in first financing round more >